ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 84 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $267,000 | -7.0% | 42,951 | +0.0% | 0.00% | – |
| Q3 2022 | $287,000 | +0.3% | 42,939 | -4.4% | 0.00% | – |
| Q2 2022 | $286,000 | +232.6% | 44,909 | +144.1% | 0.00% | – |
| Q1 2022 | $86,000 | -84.8% | 18,399 | -83.7% | 0.00% | – |
| Q4 2021 | $564,000 | +72.5% | 112,644 | +1782.7% | 0.00% | – |
| Q1 2020 | $327,000 | -72.6% | 5,983 | -76.7% | 0.00% | -100.0% |
| Q2 2019 | $1,193,000 | +16.6% | 25,640 | +0.6% | 0.00% | – |
| Q1 2019 | $1,023,000 | -13.0% | 25,495 | -0.3% | 0.00% | -100.0% |
| Q4 2018 | $1,176,000 | +189.7% | 25,565 | +178.9% | 0.00% | – |
| Q3 2018 | $406,000 | -73.9% | 9,165 | -57.3% | 0.00% | -100.0% |
| Q1 2018 | $1,553,000 | -6.5% | 21,472 | -14.9% | 0.00% | 0.0% |
| Q4 2017 | $1,661,000 | +33.1% | 25,234 | +1.3% | 0.00% | 0.0% |
| Q3 2017 | $1,248,000 | -21.4% | 24,913 | -27.3% | 0.00% | 0.0% |
| Q2 2017 | $1,587,000 | +5.9% | 34,281 | -19.1% | 0.00% | 0.0% |
| Q1 2017 | $1,498,000 | -8.0% | 42,391 | +141.0% | 0.00% | 0.0% |
| Q1 2015 | $1,629,000 | +1.6% | 17,587 | -55.6% | 0.00% | 0.0% |
| Q4 2014 | $1,603,000 | – | 39,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |